Allen Fienberg Net Worth & Insider Trades
Allen Fienberg - VP Business Development, Intra-Cellular Therapies, Inc
What is Allen Fienberg's Net Worth?
The current estimated net worth of Intra-Cellular Therapies, Inc's VP Business Development, Allen Fienberg, is estimated to be about $13.64M . Allen Fienberg owns about 197,823 units of Intra-Cellular Therapies, Inc common stock. In the last year at Intra-Cellular Therapies, Inc, Allen Fienberg has sold an estimated value of $404.06K worth.
What is Allen Fienberg's Past Insider Trading?
Allen Fienberg's largest purchase order was 12,500 units , worth over $17K on September 11, 2015. Allen Fienberg's largest sale order was 10,200 units , worth over $309.06K on September 11, 2015. In total, Allen Fienberg has made about 6 transactions over a year of their time at Intra-Cellular Therapies, Inc. Allen Fienberg usually trades in January, with the busiest year in 2015.
Allen Fienberg
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Allen Fienberg's' Mailing Address?
- Mailing address is C/o Intra-Cellular Therapies, Inc. 3960 Broadway New York NY 10032 NY
Intra-Cellular Therapies, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Sharon Mates, Ph.D. | 2020 | $766,800 | $690,120 | $2,799,998 | $1,199,994 | $18,767 | $5,475,679 |
| Sharon Mates, Ph.D. | 2019 | $744,500 | $759,400 | $1,599,996 | $1,600,003 | $20,661 | $4,724,560 |
| Sharon Mates, Ph.D. | 2018 | $722,800 | $585,500 | $1,593,735 | $1,556,410 | $18,024 | $4,476,469 |
| Lawrence J. Hineline | 2020 | $463,400 | $222,432 | $1,049,984 | $449,993 | $20,374 | $2,206,183 |
| Lawrence J. Hineline | 2019 | $449,900 | $225,000 | $749,988 | $749,995 | $18,648 | $2,193,531 |
| Lawrence J. Hineline | 2018 | $424,400 | $203,700 | $749,986 | $732,430 | $17,292 | $2,127,808 |
| Suresh Durgam, M.D. | 2020 | $448,575 | $274,400 | $599,984 | $599,997 | $7,385 | $1,930,341 |
| Michael I. Halstead | 2020 | $512,000 | $320,000 | $1,119,985 | $479,990 | $17,931 | $2,449,906 |
| Michael I. Halstead | 2019 | $497,100 | $323,100 | $749,988 | $749,995 | $17,270 | $2,337,453 |
| Michael I. Halstead | 2018 | $469,000 | $225,100 | $749,986 | $732,430 | $16,680 | $2,193,196 |
| Mark Neumann | 2020 | $518,900 | $324,312 | $1,119,985 | $479,990 | $130,085 | $2,573,272 |
| Mark Neumann | 2019 | $503,800 | $277,100 | $799,991 | $799,997 | $133,449 | $2,514,337 |
| Mark Neumann | 2018 | $106,090 | $245,500 | $749,995 | $749,990 | $25,124 | $1,876,699 |
| Andrew Satlin, M.D. | 2020 | $480,634 | $0 | $1,119,985 | $479,990 | $20,585 | $2,101,194 |
| Andrew Satlin, M.D. | 2019 | $515,000 | $360,500 | $874,997 | $874,996 | $19,332 | $2,644,825 |
| Andrew Satlin, M.D. | 2018 | $500,000 | $300,000 | $0 | $0 | $11,792 | $811,792 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1567514/000119312521140765/d80913ddef14a.htm
What are Intra-Cellular Therapies, Inc's Past Insider Trades?
Intra-Cellular Therapies, Inc's most recent insider trade came on April 19, 2023 by Robert Nostrand Van who sold 10,000 units worth $630K . In the last 9 years, insiders at Intra-Cellular Therapies, Inc have sold an estimated value of $123.34M and bought an estimated value of $64.62M worth of shares. Insider trading is most common in January, with the busiest year in 2020. The most active traders at the company are Christopher Alafi, Director, Rory Riggs, Director, and Robert Nostrand Van, Director .
Intra-Cellular Therapies, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||